Your browser doesn't support javascript.
loading
Breast cancer in the oldest old (≥ 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review.
Di Lascio, Simona; Tognazzo, Enrico; Bigiotti, Sara; Bonollo, Marta; Costa, Alberto; Pagani, Olivia; Meani, Francesco.
Afiliación
  • Di Lascio S; Oncology Institute of Southern Switzerland - IOSI, Bellinzona, Switzerland; CSSI, Centro di Senologia Della Svizzera Italiana, Ente Ospedaliero Cantonale - EOC, Switzerland. Electronic address: simona.dilascio@eoc.ch.
  • Tognazzo E; Gynecology and Obstetric Department, Ente Ospedaliero Cantonale - EOC, Lugano, Switzerland. Electronic address: enrico.tognazzo@hcuge.ch.
  • Bigiotti S; Gynecology and Obstetric Department, Ente Ospedaliero Cantonale - EOC, Lugano, Switzerland.
  • Bonollo M; Gynecology and Obstetric Department, Ente Ospedaliero Cantonale - EOC, Lugano, Switzerland.
  • Costa A; CSSI, Centro di Senologia Della Svizzera Italiana, Ente Ospedaliero Cantonale - EOC, Switzerland; European School of Oncology - ESO, Milano, Italy.
  • Pagani O; European School of Oncology - ESO, Milano, Italy; Interdisciplinary Cancer Service, Hopital Riviera-Chablais, Rennaz, Vaud, Geneva University Hospitals, Switzerland.
  • Meani F; CSSI, Centro di Senologia Della Svizzera Italiana, Ente Ospedaliero Cantonale - EOC, Switzerland; Gynecology and Obstetric Department, Ente Ospedaliero Cantonale - EOC, Lugano, Switzerland.
Eur J Surg Oncol ; 47(4): 796-803, 2021 04.
Article en En | MEDLINE | ID: mdl-33097334
ABSTRACT

INTRODUCTION:

Risk of breast cancer increases with age and very few data are available in patients older than 89.

METHODS:

A retrospective analysis on patients aged 89 and older treated between 2008 and 2019 at our certified breast center. The aim was to analyze clinical characteristics, decision-making, treatment, outcomes and open questions regarding this subpopulation for which there is a lack of guidelines.

RESULTS:

58 patients included. Tumor characteristics were analyzed, 85% patients underwent surgery of which 44% had a mastectomy. The median follow-up and overall survival were 20 and 76 months, respectively.The median survival of metastatic and non-metastatic patients were 14 and 50 months, respectively. Most patients did not receive any adjuvant treatment and among these 14% had a relapse.

CONCLUSIONS:

Elderly patients should not be under or over-treated because of their age; they represent a large heterogeneous group deserving a sub-stratification for a better tailored treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma in Situ / Carcinoma Lobular / Carcinoma Ductal de Mama / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Límite: Aged80 Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Carcinoma in Situ / Carcinoma Lobular / Carcinoma Ductal de Mama / Recurrencia Local de Neoplasia Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Límite: Aged80 Idioma: En Revista: Eur J Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article